Measles Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age
Condition:   Measles; Mumps; Rubella; Chickenpox Interventions:   Biological: Investigational MMRV(H)NS vaccine;   Biological: Investigational MM(H)RVNS vaccine;   Biological: Investigational M(L)M(L)R(L)V(L)NS vaccine;   Biological: Marketed MMRV_Lot 1 and Lot 2 vaccine Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2022 Category: Research Source Type: clinical trials

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
Condition:   Measles Intervention:   Sponsor:   The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2022 Category: Research Source Type: clinical trials